Tomorrow’s biontech: venture capitalists reveal Germany’s biotech hopes
Frankfurt The success of the Covid-19 vaccine developer Biontech has brought new attention to German biotech companies. However, regardless of the success of Biontech, the industry has again moved more into the focus of venture capitalists, even if financing and production are still more difficult in Germany than in the USA. The cancer specialist is … Read more